We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » UK Cost Watchdog Recommends Two Drugs, but Turns Down a Third
UK Cost Watchdog Recommends Two Drugs, but Turns Down a Third
The National Institute for Health and Care Excellence yesterday recommended that the National Health Service cover drugs for acute coronary syndrome and type 2 diabetes, but turned down one for multiple myeloma.